These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 6261143)

  • 1. Selective antagonists of benzodiazepines.
    Hunkeler W; Möhler H; Pieri L; Polc P; Bonetti EP; Cumin R; Schaffner R; Haefely W
    Nature; 1981 Apr; 290(5806):514-6. PubMed ID: 6261143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unusual interactions of benzodiazepine receptor antagonists.
    Nutt DJ; Cowen PJ; Little HJ
    Nature; 1982 Feb; 295(5848):436-8. PubMed ID: 6276771
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo bidirectional modulatory effect of benzodiazepine receptor ligands on GABAergic transmission evaluated by positron emission tomography in non-human primates.
    Brouillet E; Chavoix C; Bottlaender M; Khalili-Varasteh M; Hantraye P; Fournier D; Dodd RH; Mazière M
    Brain Res; 1991 Aug; 557(1-2):167-76. PubMed ID: 1660750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of the antiaversive and anticonvulsant actions of diazepam, but not of progabide, by a selective antagonist of benzodiazepine receptors.
    Lloyd KG; Bovier P; Broekkamp CL; Worms P
    Eur J Pharmacol; 1981 Oct; 75(1):77-8. PubMed ID: 6274659
    [No Abstract]   [Full Text] [Related]  

  • 5. Benzodiazepine antagonist Ro 15-1788: neurological and behavioral effects.
    Bonetti EP; Pieri L; Cumin R; Schaffner R; Pieri M; Gamzu ER; Müller RK; Haefely W
    Psychopharmacology (Berl); 1982; 78(1):8-18. PubMed ID: 6292984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of adenosine accumulation by a CNS benzodiazepine antagonist (Ro 15-1788) and a peripheral benzodiazepine receptor ligand (Ro 05-4864).
    Morgan PF; Lloyd HG; Stone TW
    Neurosci Lett; 1983 Oct; 41(1-2):183-8. PubMed ID: 6417576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Afferent stimulation frequency modulates GABAergic phenomena in the spinal cord: reversal by benzodiazepine antagonists.
    Polc P; Ducić I
    Brain Res; 1990 Oct; 531(1-2):286-9. PubMed ID: 1963101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzodiazepine antagonists abolish electrophysiological effects of sodium valproate in the rat.
    Morag M; Myslobodsky M
    Life Sci; 1982 May; 30(19):1671-7. PubMed ID: 6285103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of an atypical benzodiazepine, Ro 5-4864.
    Pellow S; File SE
    Neurosci Biobehav Rev; 1984; 8(3):405-13. PubMed ID: 6095153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacological properties of the imidazobenzodiazepine, FG 8205, a novel partial agonist at the benzodiazepine receptor.
    Tricklebank MD; Honoré T; Iversen SD; Kemp JA; Knight AR; Marshall GR; Rupniak NM; Singh L; Tye S; Watjen F
    Br J Pharmacol; 1990 Nov; 101(3):753-61. PubMed ID: 1963808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiogenic and non-anxiogenic benzodiazepine antagonists.
    Prado de Carvalho LP; Grecksch G; Chapouthier G; Rossier J
    Nature; 1983 Jan; 301(5895):64-6. PubMed ID: 6296684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodiazepine antagonist Ro 15-1788 counteracts the prolactin-lowering effects of other benzodiazepines in rats.
    Lotz W
    Neuroendocrinology; 1982; 35(1):32-6. PubMed ID: 6287328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?
    Mullen KD; Martin JV; Mendelson WB; Bassett ML; Jones EA
    Lancet; 1988 Feb; 1(8583):457-9. PubMed ID: 2893876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific proconvulsant action of an imidazobenzodiazepine (RO 15-1788) on isoniazid convulsions.
    Corda MG; Costa E; Guidotti A
    Neuropharmacology; 1982 Jan; 21(1):91-4. PubMed ID: 6278356
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular aspects of the action of benzodiazepine and non-benzodiazepine anxiolytics: a hypothetical allosteric model of the benzodiazepine receptor complex.
    Williams M
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(2):209-47. PubMed ID: 6146163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonists of benzodiazepines.
    Haefely W
    Encephale; 1983; 9(4 Suppl 2):143B-150B. PubMed ID: 6144509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the benzodiazepine antagonists, CGS 8216 and Ro 15-1788, with central adenosine A-1 receptors.
    Williams M; Risley EA
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):50-3. PubMed ID: 6299218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological actions of benzodiazepines.
    Geller HM; Hoffer BJ; Taylor DA
    Fed Proc; 1980 Oct; 39(12):3016-23. PubMed ID: 6252064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central actions of benzodiazepines: general introduction.
    Haefely WE
    Br J Psychiatry; 1978 Sep; 133():231-8. PubMed ID: 212151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligands for the benzodiazepine binding site--a survey.
    Teuber L; Wätjens F; Jensen LH
    Curr Pharm Des; 1999 May; 5(5):317-43. PubMed ID: 10213798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.